+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Nordics Seasonal Influenza Vaccination Market Forecast

  • ID: 4188637
  • Report
  • March 2017
  • Region: Global, Denmark, Finland, Iceland, Norway, Sweden
  • 90 Pages
  • Renub Research
1 of 4

Enquire about COVID-19 updates for this product.

Enquire Now
Sweden has the Highest Seasonal Influenza Vaccine Market Share

According to this report, Sweden is having the highest seasonal influenza vaccine market share.

In terms of children vaccination, Sweden & Denmark hold nearly 70 percent market share in 2016 whereas, in adult vaccination segments, these two will share more than 60 percent market share by 2022.

This report provides a complete analysis of 5 Nordic countries (Denmark, Finland, Iceland, Norway and Sweden) Seasonal Influenza Vaccine Market for Childhood & Adolescent, Number of Vaccinated Population for Childhood & Adolescent and Forecast till 2022.

All the 5 countries in the report have been studied from 2 viewpoints:

1. Seasonal Influenza Vaccine Market in Nordic Countries (2011 - 2022)

  • Seasonal Influenza Vaccine Market & Forecast
  • Children Seasonal Influenza Vaccine Market & Forecast
  • Adult Seasonal Influenza Vaccine Market & Forecast

2. Seasonal Influenza Vaccinated Population in Nordic Countries (2011 - 2022)

  • Seasonal Influenza Vaccinated Population & Forecast
  • Children Seasonal Influenza Vaccinated Population & Forecast
  • Adult Seasonal Influenza Vaccinated Population & Forecast

Countries studied in the report are as follows:

  • Denmark
  • Finland
  • Iceland
  • Norway
  • Sweden

Note: This report offers 10% free customization.
Note: Product cover images may vary from those shown
2 of 4

1. Executive Summary

2. Nordic Countries Seasonal Influenza Vaccinated Population
    2.1 Seasonal Influenza Vaccinated Child Population in Nordic Countries
    2.2 Seasonal Influenza Vaccinated Adult Population in Nordic Countries

3. Nordic Countries Seasonal Influenza Vaccine Market
    3.1 Seasonal Influenza Child Vaccine Market in Nordic Countries
    3.2 Seasonal Influenza Adult Vaccine Market in Nordic Countries

4. Nordic Countries Seasonal Influenza Vaccine Market Share Analysis
    4.1 Nordic Countries Seasonal Influenza Vaccine Market Share
    4.2 Nordic Countries Seasonal Influenza Child Vaccine Market Share
    4.3 Nordic Countries Seasonal Influenza Adult Vaccine Market Share

5. Denmark
    5.1 Denmark Seasonal Influenza Vaccinated Total Population
        5.1.1 Denmark Seasonal Influenza Vaccinated Child Population
        5.1.2 Denmark Seasonal Influenza Vaccinated Adult Population
    5.2 Denmark Seasonal Influenza Vaccine Market
        5.2.1 Denmark Seasonal Influenza Child Vaccine Market
        5.2.2 Denmark Seasonal Influenza Adult Vaccine Market

6. Finland
    6.1 Finland Seasonal Influenza Vaccinated Total Population
        6.1.1 Finland Seasonal Influenza Vaccinated Child Population
        6.1.2 Finland Seasonal Influenza Vaccinated Adult Population
    6.2 Finland Seasonal Influenza Vaccine Market
        6.2.1 Finland Seasonal Influenza Child Vaccine Market
        6.2.2 Finland Seasonal Influenza Adult Vaccine Market

7. Iceland
    7.1 Iceland Seasonal Influenza Vaccinated Total Population
        7.1.1 Iceland Seasonal Influenza Vaccinated Child Population
        7.1.2 Iceland Seasonal Influenza Vaccinated Adult Population
    7.2 Iceland Seasonal Influenza Vaccine Market
        7.2.1 Iceland Seasonal Influenza Child Vaccine Market
        7.2.2 Iceland Seasonal Influenza Adult Vaccine Market

8. Norway
    8.1 Norway Seasonal Influenza Vaccinated Total Population
        8.1.1 Norway Seasonal Influenza Vaccinated Child Population
        8.1.2 Norway Seasonal Influenza Vaccinated Adult Population
    8.2 Norway Seasonal Influenza Vaccine Market
        8.2.1 Norway Seasonal Influenza Child Vaccine Market
        8.2.2 Norway Seasonal Influenza Adult Vaccine Market

9. Sweden
    9.1 Sweden Seasonal Influenza Vaccinated Total Population
        9.1.1 Sweden Seasonal Influenza Vaccinated Child Population
        9.1.2 Sweden Seasonal Influenza Vaccinated Adult Population
    9.2 Sweden Seasonal Influenza Vaccine Market
        9.2.1 Sweden Seasonal Influenza Child Vaccine Market
        9.2.2 Sweden Seasonal Influenza Adult Vaccine Market

10. Seasonal Influenza Vaccine - Growth Drivers
    10.1 Vaccine Manufacturers Plan to Increase Flu Vaccine Production
    10.2 Growing Child & Ageing Population in Nordic Region
    10.3 Rising Healthcare Expenditure Share of the Nordic Countries GDP

11. Seasonal Influenza Vaccine - Challenges
    11.1 Regulatory Challenges with New and Novel Influenza Vaccines
    11.2 Lack of Healthcare Infrastructure
    11.3 Limited Reimbursement and Access to the Vaccines

List of Figures
Figure 2 1: Nordic Countries - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 2 2: Nordic Countries - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 2 3: Nordic Countries - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 2 4: Nordic Countries - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 2 5: Nordic Countries - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 2 6: Nordic Countries - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 3 1: Nordic Countries - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 2: Nordic Countries - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 3: Nordic Countries - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 4: Nordic Countries - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 3 5: Nordic Countries - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 3 6: Nordic Countries - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 4 1: Nordic Countries - Seasonal Influenza Vaccine Market Share (Percent), 2011 - 2016
Figure 4 2: Nordic Countries - Forecast for Seasonal Influenza Vaccine Market Share (Percent), 2017 - 2022
Figure 4 3: Nordic Countries - Seasonal Influenza Child Vaccine Market Share (Percent), 2011 - 2016
Figure 4 4: Nordic Countries - Forecast for Seasonal Influenza Child Vaccine Market Share (Percent), 2017 - 2022
Figure 4 5: Nordic Countries - Seasonal Influenza Adult Vaccine Market Share (Percent), 2011 - 2016
Figure 4 6: Nordic Countries - Forecast for Seasonal Influenza Adult Vaccine Market Share (Percent), 2017 - 2022
Figure 5 1: Denmark - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 5 2: Denmark - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 5 3: Denmark - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 5 4: Denmark - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 5 5: Denmark - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 5 6: Denmark - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 5 7: Denmark - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 8: Denmark - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 9: Denmark - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 10: Denmark - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 5 11: Denmark - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 5 12: Denmark - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 1: Finland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 6 2: Finland - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 6 3: Finland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 6 4: Finland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 6 5: Finland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 6 6: Finland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 6 7: Finland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 8: Finland - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 9: Finland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 10: Finland - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 6 11: Finland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 6 12: Finland - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 1: Iceland - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 7 2: Iceland - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 7 3: Iceland - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 7 4: Iceland - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 7 5: Iceland - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 7 6: Iceland - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 7 7: Iceland - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 8: Iceland - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 9: Iceland - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 10: Iceland - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 7 11: Iceland - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 7 12: Iceland - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 1: Norway - Seasonal Influenza Vaccinated Total Population (Thousand), 2011 - 2016
Figure 8 2: Norway - Forecast for Seasonal Influenza Vaccinated Total Population (Thousand), 2017 - 2022
Figure 8 3: Norway - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 8 4: Norway - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 8 5: Norway - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 8 6: Norway - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 8 7: Norway - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 8: Norway - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 9: Norway - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 10: Norway - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 8 11: Norway - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 8 12: Norway - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 1: Sweden - Seasonal Influenza Vaccinated Population (Thousand), 2011 - 2016
Figure 9 2: Sweden - Forecast for Seasonal Influenza Vaccinated Population (Thousand), 2017 - 2022
Figure 9 3: Sweden - Seasonal Influenza Vaccinated Child Population (Thousand), 2011 - 2016
Figure 9 4: Sweden - Forecast for Seasonal Influenza Vaccinated Child Population (Thousand), 2017 - 2022
Figure 9 5: Sweden - Seasonal Influenza Vaccinated Adult Population (Thousand), 2011 - 2016
Figure 9 6: Sweden - Forecast for Seasonal Influenza Vaccinated Adult Population (Thousand), 2017 - 2022
Figure 9 7: Sweden - Seasonal Influenza Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 8: Sweden - Forecast for Seasonal Influenza Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 9: Sweden - Seasonal Influenza Child Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 10: Sweden - Forecast for Seasonal Influenza Child Vaccine Market (Thousand US$), 2017 - 2022
Figure 9 11: Sweden - Seasonal Influenza Adult Vaccine Market (Thousand US$), 2011 - 2016
Figure 9 12: Sweden - Forecast for Seasonal Influenza Adult Vaccine Market (Thousand US$), 2017 - 2022
Figure 10 1: Vaccine Manufacturers - Influenza Vaccine Production (Million Doses), 2013-2015
Figure 10 2: Nordic Countries - Child Population (Thousand), 2010 - 2016
Figure 10 3: Nordic Countries - Forecast for Child Population (Thousand), 2017 - 2022
Figure 10 4: Nordic Countries - Ageing Population (Thousand), 2010 - 2016
Figure 10 5: Nordic Countries - Forecast for Ageing Population (Thousand), 2017 - 2022

List of Tables
Table 10 1: Nordic Countries - Healthcare Expenditure Share (Percent) of GDP, 2005 - 2015

Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4

In this report, for analyzing the future trends for the studied market during the forecast period, the publisher has incorporated rigorous statistical and econometric methods, further scrutinized by secondary, primary sources and by in-house experts, supported through their extensive data intelligence repository. The market is studied holistically from both demand and supply-side perspectives. This is carried out to analyze both end-user and producer behavior patterns, in the review period, which affects price, demand and consumption trends. As the study demands to analyze the long-term nature of the market, the identification of factors influencing the market is based on the fundamentality of the study market.

Through secondary and primary researches, which largely include interviews with industry participants, reliable statistics, and regional intelligence, are identified and are transformed to quantitative data through data extraction, and further applied for inferential purposes. The publisher's in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of their recommendations and advice.

Primary Research

The primary purpose of this phase is to extract qualitative information regarding the market from the key industry leaders. The primary research efforts include reaching out to participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions. The publisher also established professional corporate relations with various companies that allow us greater flexibility for reaching out to industry participants and commentators for interviews and discussions, fulfilling the following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develop the analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth, and forecast

The researcher's primary research interview and discussion panels are typically composed of the most experienced industry members. These participants include, however, are not limited to:

  • Chief executives and VPs of leading corporations specific to the industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investment, and valuation experts
  • Key opinion leaders (KOLs)

Secondary Research

The publisher refers to a broad array of industry sources for their secondary research, which typically includes, however, is not limited to:

  • Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, webcasts, and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecasts
 

Loading
LOADING...

Adroll
adroll